Follow on Twitter
Subscribe by RSS
Archive for: therapeutics
Plasma Protein Therapeutics Market to Reach $44,296.78 million, Globally, by 2031 at 5.2% CAGR: Allied Market Research
/ Business
Ground-breaking results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients
/ Business
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Announces Record and Meeting Dates for its first Annual Meeting of Stockholders
/ Business
Talaris Therapeutics Presents Additional Phase 2 Data and Analyses at American Transplant Congress 2022
/ Business
